Venus Medtech (Hangzhou) Inc. (HKG:2500)

Venus Medtech (Hangzhou) Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	279	298.04	774.4	1,879	2,955	2,708
Short-Term Investments	14.31	7.67	7.24	-	-	-
Cash & Short-Term Investments	293.31	305.7	781.64	1,879	2,955	2,708
Cash Growth	-39.63%	-60.89%	-58.41%	-36.40%	9.12%	12.22%
Accounts Receivable	137.53	198.57	290.61	303.39	302.1	231.03
Other Receivables	-	55.04	58.27	80.75	53.8	44.55
Receivables	247.3	362.17	455.05	384.14	355.89	275.58
Inventory	104.17	98.06	112.94	104.4	90.52	59.9
Prepaid Expenses	-	-	0.28	1.07	1.02	0.78
Other Current Assets	87.85	36.54	258.17	99.93	36.98	316
Total Current Assets	732.62	802.48	1,608	2,469	3,440	3,360
Property, Plant & Equipment	501.44	522.11	693.47	461.28	250.75	100.01
Long-Term Investments	396.07	414.59	510	477.08	569.53	108.99
Goodwill	1,035	1,040	1,024	1,239	519.71	487.32
Other Intangible Assets	419.14	439.72	551.02	611.17	304.74	233
Long-Term Deferred Tax Assets	28.41	24.47	17.66	9.94	8.17	1.16
Other Long-Term Assets	7	6.76	9.15	15.86	16.93	27.32
Total Assets	3,120	3,250	4,414	5,283	5,109	4,318
Accounts Payable	22.42	30.23	33.86	9.13	8.75	5.3
Accrued Expenses	-	52.41	35.12	44.91	41.71	37.5
Short-Term Debt	161.13	17.52	136.83	100.12	0.5	-
Current Portion of Long-Term Debt	-	-	320.14	122.49	4.4	-
Current Portion of Leases	40.73	38.59	37.72	23.46	17.73	11.09
Current Income Taxes Payable	-	0.06	2.16	5.01	0.48	-
Current Unearned Revenue	4.65	3.21	29.54	4.32	17.84	16.49
Other Current Liabilities	174.39	219.74	209.79	182.68	117.13	335.15
Total Current Liabilities	403.32	361.75	805.17	492.1	208.53	405.52
Long-Term Debt	258.44	265.46	248.93	573.38	-	-
Long-Term Leases	33.29	47.53	82.56	80.2	48.15	21.67
Long-Term Unearned Revenue	1.83	-	1.63	0.6	-	1.06
Long-Term Deferred Tax Liabilities	-	-	17.78	17.41	53.45	32.94
Other Long-Term Liabilities	356.87	363.94	338.31	487.83	167.48	-
Total Liabilities	1,054	1,039	1,494	1,652	477.61	461.19
Common Stock	441.01	441.01	441.01	441.01	441.01	422.97
Additional Paid-In Capital	5,112	5,112	5,112	5,112	5,112	3,939
Retained Earnings	-3,731	-3,596	-2,882	-2,178	-1,120	-746.72
Treasury Stock	-72.55	-72.55	-72.55	-72.55	-72.55	-
Comprehensive Income & Other	316.42	326.48	321.72	305.18	185.25	200.19
Total Common Equity	2,066	2,211	2,921	3,608	4,546	3,815
Minority Interest	-	-	-1.3	23.45	86.21	41.61
Shareholders' Equity	2,066	2,211	2,919	3,631	4,632	3,857
Total Liabilities & Equity	3,120	3,250	4,414	5,283	5,109	4,318
Total Debt	493.59	369.09	826.19	899.64	70.78	32.76
Net Cash (Debt)	-200.28	-63.39	-44.55	979.79	2,884	2,675
Net Cash Growth	-	-	-	-66.03%	7.81%	18.02%
Net Cash Per Share	-0.46	-0.14	-0.10	2.24	6.58	6.54
Filing Date Shares Outstanding	437.9	437.9	437.9	437.9	437.9	422.97
Total Common Shares Outstanding	437.9	437.9	437.9	437.9	437.9	422.97
Working Capital	329.3	440.73	802.9	1,977	3,231	2,955
Book Value Per Share	4.72	5.05	6.67	8.24	10.38	9.02
Tangible Book Value	611.79	731.74	1,345	1,758	3,721	3,095
Tangible Book Value Per Share	1.40	1.67	3.07	4.01	8.50	7.32
Machinery	-	156.38	170.96	147.48	83.65	53.7
Construction In Progress	-	427.18	394.6	162.14	54.89	22.98
Leasehold Improvements	-	81.66	96.62	91.21	44.26	19.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.